| Betterchem |

|
|
| FDA approval activities
for this prescription drug:
OptiMark (gadoversetamide) Injection, Tyco/Mallinckrodt Health Care NDA 20-937/S3 NDA 20-975/S3 NDA 20-976/S3 1/31/03 2/12/03 2/13/03 OptiMark (gadoversetamide) Injection Mallinckrodt, NDA 20-937 NDA 20-975 NDA 20-976 |
© 2007 Betterchem Corp.
|